<unk>  is a chemotherapy drug that is FDA approved to treat AIDS-related Kaposi's sarcoma.  It is also commonly used to treat specific types of leukaemia and non-Hodgkin lymphoma.<unk>  is intravenously administered.  It utilizes the<unk>  carrier system that provides a favorable pharmacokinetic profile at the site of KS lesions resulting in a 10-fold increase in concentrations compared to that which is achieved with conventional preparations.
Trade name: DaunoXome®
Liposomal daunorubicin
Daunorubicin / cytarabine
Cytarabine liposome
Epirubicin hydrochloride
Irinotecan hydrochloride 
Doxorubicin liposome
Doxorubicin hydrochloride
Dihydroergocristine